Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Effects of systemic immunotherapy on olfactory function in allergic rhinitis patients
Deniz Tansuker1, Berna Uslu Coşkun, Yusuf Orhan Uçal
1From the *Department of Otolaryngology, Devrek State Hospital, Devrek, Zonguldak; †Department of Otolaryngology, Sisli Etfal Training and Research Hospital, Istanbul; ‡Department of Otolaryngology, Ercis State Hospital, Ercis, Van; and §Department of Otolaryngology, Hisar Intercontinental Hospital, and ∥Department of Otolaryngology, Safa Hospital, Istanbul, Turkey.
Subcutaneous systemic immunotherapy (SIT) improved olfactory identification scores in allergic rhinitis patients. Further research is needed to confirm SIT as a curative treatment for smell dysfunction in allergic rhinitis.
Area of Science:
- Otolaryngology
- Immunology
- Allergology
Background:
- Allergic rhinitis (AR) affects 20% of the global population, often leading to olfactory dysfunction.
- Current treatments for AR manage symptoms but do not offer a cure.
- Systemic immunotherapy (SIT) is the only potentially curative treatment for AR, but its impact on olfactory function requires further investigation.
Purpose of the Study:
- To quantitatively assess the effect of subcutaneous SIT on olfactory function in patients with allergic rhinitis.
- To analyze changes in smell test parameters before and after SIT treatment.
Main Methods:
- A cohort of 12 allergic rhinitis patients undergoing subcutaneous SIT was studied.
- Olfactory function was evaluated using the 3-step "Sniffin' Sticks" test before and 18 months after SIT.
- Pre- and post-treatment data were compared for each patient.
Main Results:
- Patients showed increased average scores across smell test parameters post-treatment.
- A significant improvement was observed in the mean olfactory identification score (P < 0.05).
- No significant relationship was found between age, sex, smoking status, and changes in olfactory parameters.
Conclusions:
- Subcutaneous SIT demonstrates a positive effect on improving olfactory performance in allergic rhinitis patients.
- Larger-scale studies with extended follow-up are recommended to validate SIT as a treatment for olfactory disorders in AR.
Related Concept Videos
Olfactory Receptors: Location and Structure
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Reactions
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

